Share this Post!

Pursuant to Republic Act No. (RA) 11346 and RA 11467, the Food and Drug Administration (FDA) publishes the following revised draft guidelines on the regulation of Vapor Products for the second public consultation of the proposed policy:

1)    General Guidelines for the Regulation of Vapor Products

1.1   Annex A – Vapor Product Refill and Cartridge Standards

1.2   Annex B – Packaging and Labeling Requirements for Vapor Product Refills and Cartridges

1.3   Annex C – Labeling Requirements for Vapor Product Electronic Delivery Devices

1.4   Annex D – Glossary

2)     Licensing Guidelines

2.1   Annex A – Online User’s Registration Form

2.2   Annex B – Template for the Authorization Letter

2.3   Annex C – Documentary Requirements for LTO Application

2.4   Annex D – Fees and Charges for LTO Application

3)    Product Marketing Authorization Guidelines for Vapor Products

       3.1. Annex A – Guidelines for the Preparation of Product Information File (PIF) for Vapor Products

       3.2 Annex B – Schedule of Fees

4)    Guidelines for the Issuance of Pre-Application Documentary Evaluation for Vapor Products

5)     Batch Declaration of Vapor Products

Following the initial online posting of the draft guidelines dated 08 April 2020, the FDA had consolidated, discussed, and reviewed all received comments from 08 April to 30 June 2020, and had taken all submissions into consideration during the revision of the draft guidelines.

Kindly send your comments through email at [email protected] on or before 30 July 2020.

For your information and guidance.